The House Energy and Commerce Health Subcommittee today concluded a two-day hearing on more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies, which follows a similar hearing last month on 25 other bills. Witnesses at the latest hearing included Michael Botticelli, executive director of the Grayken Center for Addiction at Boston Medical Center, and John Kravitz, chief information officer for Danville, PA-based Geisinger Health System. Botticelli, a former director of the White House Office of National Drug Control Policy and Massachusetts Bureau of Substance Addiction Services, emphasized the “critical role” that Medicaid plays in addressing the opioid epidemic. Kravitz described how the integrated health system has used electronic prescribing and information technology strategies to reduce opioid prescriptions, drug diversion and the cost of care. The Senate Health, Education, Labor and Pensions Committee yesterday held a hearing on a discussion draft of bipartisan legislation to address the opioid crisis, which the committee will mark up on April 24. 

Headline
The Centers for Medicare & Medicaid Services is seeking comments by May 11 on its proposed revisions to data reporting requirements for Medicare Advantage…
Headline
The Medicare Payment Advisory Commission March 12 released its March 2026 report to Congress, which includes its recommended payment rates for hospital…
Headline
The Centers for Medicare & Medicaid Services March 11 issued guidance to state survey agency directors clarifying and reinforcing the roles and…
Headline
The Medicaid and CHIP Payment and Access Commission March 12 released its March 2026 report to Congress. The first chapter includes a recommendation to…
Headline
The Joint Economic Committee March 10 released a report that found Medicare Part B premiums rose last year due to Medicare Advantage overpayments. The…
Headline
The Centers for Medicare & Medicaid Services March 6 issued guidance to states on transitioning to six-month Medicaid redeterminations in 2027, a change…